Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew R. Robbins currently holds 1,025,000 shares of ARRAY BIOPHARMA INC (ARRY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew R. Robbins has been a net seller of ARRY stock. They have purchased $0 and sold $8.2M worth of shares.
Andrew R. Robbins's most recent insider trade was on Dec 17, 2025, when they sold 840,000 shares at $0.00 per share.
Andrew R. Robbins serves as Executive at ARRAY BIOPHARMA INC (ARRY). They have executed 32 insider transactions totaling $8.2M over their tenure at the company.
Andrew R. Robbins holds the position of Executive at ARRAY BIOPHARMA INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Andrew R. Robbins has shown a selling trading pattern, with $0 in total purchases and $8.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew R. Robbins was on Dec 17, 2025, when they sold $14.5M worth of COGT shares. This transaction involved 367,497 shares at $39.45 per share.
Andrew R. Robbins currently owns 1,025,000 shares of ARRAY BIOPHARMA INC (ARRY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew R. Robbins's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew R. Robbins has 32 Form 4 filings on record as an insider at ARRAY BIOPHARMA INC.
Set alerts for Andrew R. Robbins and 40,000+ other insiders.